January 17, 2017 / 7:21 AM / 3 years ago

BRIEF-Richter, Allergan announce positive uterine fibroid medicine test

Jan 17 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt

* Hungary’s Richter and Allergan announce positive phase III clinical test results for new medicine to treat uterine fibroids.

* Ulipristal acetate is an investigational drug for the medical treatment of uterine fibroids.

* A new drug application filing for ulipristal acetate is planned for the second half of 2017. Further company coverage: (Reporting by Gergely Szakacs, editing by Louise Heavens)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below